Overexpression of hippocampal cholinergic neurostimulating peptide in heterozygous transgenic mice increases the amount of ChAT in the medial septal nucleus

Brain Research

Volumn 1305, Issue , 2009, Pages 150-157

  Uematsu, Norihiko ^a   Matsukawa, Noriyuki ^a   Kanamori, Tetsuko ^a   Arai, Yoshifumi ^a   Sagisaka, Takafumi ^a   Toyoda, Takanari ^a   Yoshida, Mari ^b   Ojika, Kosei ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Acetylcholine; ChAT; HCNP; Hippocampal cholinergic; Neurostimulating peptide; RKIP; Transgenic mouse

Indexed keywords

CHOLINE ACETYLTRANSFERASE; HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE; MESSENGER RNA; NEUROPEPTIDE; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN;

ANIMAL; ARTICLE; CELL SHAPE; CYTOLOGY; GENETICS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; METABOLISM; MOUSE; NEOSTRIATUM; NERVE CELL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTUM NUCLEUS; TRANSGENE; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL SHAPE; CHOLINE O-ACETYLTRANSFERASE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; MICE, TRANSGENIC; NEOSTRIATUM; NEURONS; NEUROPEPTIDES; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPTAL NUCLEI; TRANSGENES;

EID: 73949152596     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.09.112     Document Type: Article

References (35)

1. Cobb, S.R., Davies, C.H., 2005. Cholinergic modulation of hippocampal cells and circuits. J. Physiol. 562, 81-88. (Pubitemid 40207787)
2. Engert, F., Bonhoeffer, T., 1999. Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature 399, 66-70.
3. Francis, P.T., Palmer, A.M., Snape, M., Wilcock, G.K., 1999. The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66, 137-147. (Pubitemid 29103513)
4. 1A receptor-mediated pathways by repeated lithium treatment in rats. Can. J. Physiol. Pharmacol. 78, 392-399.
5. Harvey, C.D., Yasuda, R., Zhong, H., Svoboda, K., 2008. The spread of Ras activity triggered by activation of a single dendritic spine. Science 321, 136-140. (Pubitemid 351956251)
6. Hengst, U., Albrecht, H., Hess, D., Monard, D., 2001. The phosphatidylethanolamine-binding protein is the prototype of a novel family of serine protease inhibitors. J. Biol. Chem. 276, 535-540. (Pubitemid 32050348)
7. Iwase, T., Ojika, K., Matsukawa, N., Nishino, H., Yamamoto, T., Okada, H., Fujimori, O., Ueda, R., 2001. Muscarinic cholinergic and glutamatergic reciprocal regulation of expression of hippocampal cholinergic neurostimulating peptide precursor protein gene in rat hippocampus. Neuroscience 102, 341-352. (Pubitemid 32126488)
8. Kelleher 3rd, R.J., Govindarajan, A., Jung, H.Y., Kang, H., Tonegawa, S., 2004a. Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116, 467-479. (Pubitemid 38366322)
9. Kelleher 3rd, R.J., Govindarajan, A., Tonegawa, S., 2004b. Translational regulatory mechanisms in persistent forms of synaptic plasticity. Neuron 44, 59-73. (Pubitemid 39348830)
10. Kitamura, E., Kuemerle, B.A., Chernova, O.B., Cowell, J.K., 2001. Molecular characterization of the breakpoint region associated with a constitutional t(2;15)(q34;q26) in a patient with multiple myeloma. Cancer Genet. Cytogenet. 129, 112-119. (Pubitemid 32826302)
11. Kozak, M., 1987. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196, 947-950.
12. Lee, T.Y., Tjin Tham Sjin, R.M., Movahedi, S., Ahmed, B., Pravda, E.A., Lo, K.M., Gillies, S.D., Folkman, J., Javaherian, K., 2008. Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy. Clin. Cancer Res. 14, 1487-1493. (Pubitemid 351413933)
13. Li, S., Tian, X., Hartley, D.M., Feig, L.A., 2006a. Distinct roles for Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and Ras-GRF2 in the induction of long-term potentiation and long-term depression. J. Neurosci. 26, 1721-1729. (Pubitemid 43236984)
14. Li, S., Tian, X., Hartley, D.M., Feig, L.A., 2006b. The environment versus genetics in controlling the contribution of MAP kinases to synaptic plasticity. Curr. Biol. 16, 2303-2313. (Pubitemid 44821841)
15. Lorenz, K., Lohse, M.J., Quitterer, U., 2003. Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature 426, 574-579. (Pubitemid 37522645)
16. Maki, M., Matsukawa, N., Yuasa, H., Otsuka, Y., Yamamoto, T., Akatsu, H., Okamoto, T., Ueda, R., Ojika, K., 2002. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease. J. Neuropathol. Exp. Neurol. 61, 176-185. (Pubitemid 34127101)
17. Mamounas, L.A., Altar, C.A., Blue, M.E., Kaplan, D.R., Tessarollo, L., Lyons, W.E., 2000. BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J. Neurosci. 20, 771-782. (Pubitemid 30225579)
18. Matsukawa, N., Tooyama, I., Kimura, H., Yamamoto, T., Tsugu, Y., Oomura, Y., Ojika, K., 1999. Increased expression of hippocampal cholinergic neurostimulating peptide-related components and their messenger RNAs in the hippocampus of aged senescence-accelerated mice. Neuroscience 88, 79-92. (Pubitemid 28440393)
19. Matsukawa, N., Ikenaka, K., Nanmoku, K., Yuasa, H., Hattori, M., Kawano, M., Nakazawa, H., Fujimori, O., Ueda, R., Ojika, K., 2003. Brain malformations caused by retroviral vector-mediated gene transfer of hippocampal cholinergic neurostimulating peptide precursor protein into the CNS via embryonic mice ventricles. Dev. Neurosci. 25, 349-356. (Pubitemid 37465061)
20. Mayford, M., Baranes, D., Podsypanina, K., Kandel, E.R., 1996. The 3?-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites. Proc. Natl. Acad. Sci. U. S. A. 93, 13250-13255.
21. Ojika, K., Kojima, S., Ueki, Y., Fukushima, N., Hayashi, K., Yamamoto, M., 1992. Purification and structural analysis of hippocampal cholinergic neurostimulating peptide. Brain Res. 572, 164-171.
22. Ojika, K., Mitake, S., Kamiya, T., Kosuge, N., Taiji, M., 1994. Two different molecules, NGF and free-HCNP, stimulate cholinergic activity in septal nuclei in vitro in a different manner. Brain Res. Dev. Brain Res. 79, 1-9. (Pubitemid 24151805)
23. Ojika, K., Katada, E., Tohdoh, N., Mitake, S., Otsuka, Y., Matsukawa, N., Tsugu, Y., 1995. Demonstration of deacetylated hippocampal cholinergic neurostimulating peptide and its precursor protein in rat tissues. Brain Res. 701, 19-27.
24. Ojika, K., Tsugu, Y., Mitake, S., Otsuka, Y., Katada, E., 1998. NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro. Brain Res. Dev. Brain Res. 106, 173-180. (Pubitemid 28168483)
25. Ojika, K., Mitake, S., Tohdoh, N., Appel, S.H., Otsuka, Y., Katada, E., Matsukawa, N., 2000. Hippocampal cholinergic neurostimulating peptides (HCNP). Prog. Neurobiol. 60, 37-83. (Pubitemid 30001451)
26. Paxinos, G.W, 1988. The Rat Brain in Stereotaxic Coordinates. Academic Press, San Diego.
27. Scannevin, R.H., Huganir, R.L., 2000. Postsynaptic organization and regulation of excitatory synapses. Nat. Rev., Neurosci. 1, 133-141.
28. Shankar, G.M., Bloodgood, B.L., Townsend, M., Walsh, D.M., Selkoe, D.J., Sabatini, B.L., 2007. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866-2875. (Pubitemid 46438992)
29. Spillane, J.A., Goodhart, M.J., White, P., Bowen, D.M., Davison, A.N., 1977. Choline in Alzheimer's disease. Lancet 2, 826-827. (Pubitemid 8193266)
30. Stewart, C.V., Plenz, D., 2006. Inverted-U profile of dopamine-NMDA-mediated spontaneous avalanche recurrence in superficial layers of rat prefrontal cortex. J. Neurosci. 26, 8148-8159. (Pubitemid 44315139)
31. Sugimoto, H., Yamanishi, Y., Iimura, Y., Kawakami, Y., 2000. Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. Curr. Med. Chem. 7, 303-339. (Pubitemid 30396441)
32. Vogt, K.E., Regehr, W.G., 2001. Cholinergic modulation of excitatory synaptic transmission in the CA3 area of the hippocampus. J. Neurosci. 21, 75-83. (Pubitemid 32098728)
33. Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., Fee, F., Katsanakis, K.D., Rose, D.W., Mischak, H., et al., 1999. Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature 401, 173-177. (Pubitemid 29436321)
34. Yoshii, A., Constantine-Paton, M., 2007. BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat. Neurosci. 10, 702-711. (Pubitemid 46828509)
35. Zeng, L., Imamoto, A., Rosner, M.R., 2008. Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opin. Ther. Targets 12, 1275-1287.